Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Free light chains: Eclectic multipurpose biomarker.

Umberto Basile1, Francesca Gulli1, Laura Gragnani2

  • 1Department of Laboratory Medicine of the Catholic University of Sacred Heart, Rome, Italy.

Journal of Immunological Methods
|September 22, 2017
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cryoglobulinemia and Cryofibrinogenemia: Ten years of experience and diagnostic perspectives from a large laboratory-based cohort.

Clinical biochemistry·2026
Same author

HCV-related cryoglobulinemic vasculitis (mixed cryoglobulinemia syndrome) in the era of direct-acting antivirals: A 10-year experience from Italian tertiary referral centers.

Journal of autoimmunity·2026
Same author

Cryoglobulinemia, monoclonal and mixed cryoglobulinemia syndromes, cryoglobulinemic vasculitis: <i>a proposal for comprehensive nomenclature and definition</i>.

Frontiers in immunology·2026
Same author

Cryoglobulinemia: An update on classification, pathophysiology, clinical presentation, and management.

Journal of internal medicine·2025
Same author

Cryoproteins in Non-HCV-Related Autoimmune Disorders: A Serious Cold-Induced Problem.

Diagnostics (Basel, Switzerland)·2025
Same author

Distinct Biomarker Profiles of B-Cell Activation in Metabolic and Viral Hepatic Fibrosis.

International journal of molecular sciences·2025

Immunoglobulin light chains (κ and λ), once thought to be waste, are active molecules crucial for antibody function. Their role in inflammation highlights their potential as therapeutic targets and disease biomarkers.

Area of Science:

  • Immunology
  • Biochemistry
  • Molecular Biology

Background:

  • Antibody production involves a slight excess of immunoglobulin light chains (κ and λ).
  • These chains are found in various body fluids and are typically reabsorbed in the kidneys, appearing in urine in trace amounts.
  • Initially considered a byproduct of immunoglobulin synthesis, free light chains are now recognized as active molecules.

Purpose of the Study:

  • To review the scientific interest in immunoglobulin light chains κ and λ.
  • To report on the progress in understanding their structure and function.
  • To focus on their biological significance and potential clinical utility.

Main Methods:

  • Literature review of scientific studies on immunoglobulin light chains.
Keywords:
Autoimmune diseasesFree light chainsImmediate hypersensitivityMultiple sclerosisRituximabViral infections

Related Experiment Videos

  • Analysis of research on the structure, function, and biological activity of free light chains.
  • Examination of clinical applications and disease associations.

    • Main Results:

    • Free light chains bind antigens and whole immunoglobulins, contributing to antibody affinity.
    • They activate mast cells and play a role in the pathogenesis of chronic inflammatory diseases.
    • Their clinical utility as therapeutic targets and disease biomarkers is increasingly recognized.

    Conclusions:

    • Immunoglobulin light chains are not mere waste products but active participants in immune responses.
    • Their involvement in inflammatory processes offers significant potential for clinical applications.
    • Further research into free light chains can lead to novel therapeutic strategies and diagnostic tools.